Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2011-8-12
pubmed:abstractText
We have shown previously that the inter-domain interaction between the two domains of RyR (ryanodine receptor), CaMBD [CaM (calmodulin)-binding domain] and CaMLD (CaM-like domain), activates the Ca(2+) channel, and this process is called activation-link formation [Gangopadhyay and Ikemoto (2008) Biochem. J. 411, 415-423]. Thus CaM that is bound to CaMBD is expected to interfere the activation-link formation, thereby stabilizing the closed state of the channel under normal conditions. In the present paper, we report that, upon stimulation of neonatal cardiomyocytes with the pro-hypertrophy agonist ET-1 (endothelin-1), CaM dissociates from the RyR, which induces a series of intracellular events: increased frequency of Ca(2+) transients, translocation of the signalling molecules CaM, CaMKII (CaM kinase II) and the transcription factor NFAT (nuclear factor of activated T-cells) to the nucleus. These events then lead to the development of hypertrophy. Importantly, an anti-CaMBD antibody that interferes with activation-link formation prevented all of these intracellular events triggered by ET-1 and prevented the development of hypertrophy. These results indicate that the aberrant formation of the activation link between CaMBD and CaMLD of RyR is a key step in the development of hypertrophy in cultured cardiomyocytes.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-10387100, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-10809760, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-10935538, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-11306590, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-11796242, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-11827679, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-11866478, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-11955428, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-12707260, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-12881512, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-12975316, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-14706290, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-15276470, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-15611117, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-15656791, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-15781737, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-15951021, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-16227507, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-16339144, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-16387763, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-16624262, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-16859700, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-17332063, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-17431507, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-18171325, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-18227387, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-18996969, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-19284993, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-19900959, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-20056922, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-20226167, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-20388639, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-20433809, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-2226794, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-2434495, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-2725677, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-7516645, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-7663132, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-8319584, http://linkedlifedata.com/resource/pubmed/commentcorrection/21649588-8999838
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1470-8728
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
438
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
379-87
pubmed:meshHeading
pubmed-meshheading:21649588-Animals, pubmed-meshheading:21649588-Animals, Newborn, pubmed-meshheading:21649588-Antibodies, pubmed-meshheading:21649588-Calcium Signaling, pubmed-meshheading:21649588-Calcium-Calmodulin-Dependent Protein Kinase Type 2, pubmed-meshheading:21649588-Calmodulin, pubmed-meshheading:21649588-Cardiomegaly, pubmed-meshheading:21649588-Cell Nucleus, pubmed-meshheading:21649588-Cell Size, pubmed-meshheading:21649588-Endothelin-1, pubmed-meshheading:21649588-Intracellular Space, pubmed-meshheading:21649588-Myocytes, Cardiac, pubmed-meshheading:21649588-NFATC Transcription Factors, pubmed-meshheading:21649588-Protein Binding, pubmed-meshheading:21649588-Rats, pubmed-meshheading:21649588-Rats, Sprague-Dawley, pubmed-meshheading:21649588-Ryanodine Receptor Calcium Release Channel
pubmed:year
2011
pubmed:articleTitle
Aberrant interaction of calmodulin with the ryanodine receptor develops hypertrophy in the neonatal cardiomyocyte.
pubmed:affiliation
Boston Biomedical Research Institute, Watertown, MA 02472, USA. jaya@bbri.org
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural